Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. financial statements

Elicio Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 39.57M10-K
Cash and equivalentsUSD 18.56M10-Q
Total debtUSD 10M10-K

Elicio Therapeutics, Inc. financials on 6ix · Elicio Therapeutics, Inc. on 6ix